ALLOSOURCE, ANNOUNCES

ALLOSOURCE ANNOUNCES FIRST PATIENT IMPLANTATION IN UNITED KINGDOM CLINICAL EVALUATION OF PROCHONDRIX CR CRYOPRESERVED OSTEOCHONDRAL ALLOGRAFT

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

AlloSource United Kingdom Colorado

en | boerse | 67937156 |